Thrombolysis in acute myocardial infarction: current status

Area of Science:

• Cardiology
• Emergency Medicine
• Pharmacology

Background:

• ST-segment elevation myocardial infarction (STEMI) persists as a significant global health concern.
• Treatment paradigms for STEMI have evolved, favoring mechanical reperfusion over pharmacologic approaches.
• Timely access to mechanical reperfusion facilities remains a challenge for many STEMI patients.

Purpose of the Study:

• To review the historical context and evolution of thrombolytic therapy for STEMI.
• To examine adjunctive therapies used in conjunction with thrombolysis.
• To discuss the interplay between thrombolytic and mechanical reperfusion strategies and the future potential of thrombolysis.

Main Methods:

• Literature review of historical and contemporary studies on thrombolytic therapy for STEMI.
• Analysis of treatment guidelines and clinical trial data.
• Synthesis of information on adjunctive therapies and mechanical reperfusion.

Main Results:

• Thrombolytic therapy has a well-established history in STEMI management.
• Adjunctive therapies can enhance the efficacy of thrombolysis.
• Mechanical reperfusion is often preferred but not universally accessible, maintaining a role for thrombolysis.

Conclusions:

• Thrombolytic therapy remains a vital treatment option for STEMI, particularly in resource-limited settings.
• The integration of thrombolysis with other therapies can improve patient outcomes.
• Future strategies may involve optimized use of thrombolysis in specific patient populations or settings.